These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 12607015)

  • 1. [Factor VII, a therapeutic alternative in the treatment of severe haemoghage disorders].
    Morales León V; Herrera Ortega G; Molero Gómez R; García Cortés J
    Farm Hosp; 2003; 27(1):38-41. PubMed ID: 12607015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coagulation factor VII--new physiopathological and therapeutic aspects].
    Helleberg C; Hippe E; Ingerslev J
    Ugeskr Laeger; 1994 Aug; 156(34):4805-10. PubMed ID: 7992413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.
    Meijer K; Sieders E; Slooff MJ; de Wolf JT; van der Meer J
    Thromb Haemost; 1998 Jul; 80(1):204-5. PubMed ID: 9684815
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recombinant activated factor VII used in a man with refractory bleeding from a stab wound injuring the liver and kidney].
    Arnal D; Piñeiro P; Garutti I; Olmedilla L; Sanz J; Lajara A
    Rev Esp Anestesiol Reanim; 2004 May; 51(5):284-8. PubMed ID: 15214766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of activated recombinant FVII in the control of haemorrhage following trauma].
    Perrier V; Morel N; Bernard JC; Julliac B; Dewitte A; Pouquet O; Sztark F; Dabadie P
    Ann Fr Anesth Reanim; 2006 Sep; 25(9):990-3. PubMed ID: 16926088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].
    Veyckemans F
    Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation.
    Ghosh K; Mota L; Shetty S; Kulkarni B
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):577-80. PubMed ID: 18685441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?].
    Skalski JH; Czapla J; Nadziakiewicz P; Kaczmarski J; Zembala M
    Przegl Lek; 2002; 59(11):941-5. PubMed ID: 12715727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy.
    Hoffman R; Mahajana A; Agmon P; Baruch Y; Brenner B
    Thromb Haemost; 2002 Feb; 87(2):346-7. PubMed ID: 11858500
    [No Abstract]   [Full Text] [Related]  

  • 12. The extrinsic system.
    Triplett DA
    Clin Lab Med; 1984 Jun; 4(2):221-44. PubMed ID: 6388984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J; Wang Q; Gao F; He JW; Zhao JH
    J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature.
    Hünseler C; Kribs A; Eifinger F; Roth B
    J Perinatol; 2006 Nov; 26(11):706-13. PubMed ID: 17066067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment.
    Tsochatzis E; Papatheodoridis GV; Elefsiniotis I; Thanelas S; Theodossiades G; Moulakakis A; Archimandritis AJ
    Dig Liver Dis; 2007 May; 39(5):490-4. PubMed ID: 16787769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VII in hepatology.
    Romero Castro R; Barroso Relinque N; Caunedo Alvarez A; García Montes JM; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2001 Oct; 93(10):659-68. PubMed ID: 11767490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe intra-abdominal bleeding post liver biopsy - failure to respond to recombinant Factor VII.
    Quinn JP; Murphy PT
    Thromb Haemost; 2004 Mar; 91(3):632-3. PubMed ID: 14983243
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of diffuse alveolar hemorrhage with activated factor VII.
    Henke D; Falk RJ; Gabriel DA
    Ann Intern Med; 2004 Mar; 140(6):493-4. PubMed ID: 15023729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.